SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : DYGN - Dynagen
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ron Peterson who wrote (298)4/22/1998 6:05:00 PM
From: *ROSARIO*  Read Replies (1) of 444
 
DYGND HAD A HIGH OF $15 PER SHARE LAST JUNE. IT HAS HAD A HIGH OF OVER $60 PER SHARE. WHEN YOU ARE DEALING WITH A COMPANY THAT HAS A PATENT ON HIV MEDICATIONS THE SKY IS THE LIMIT. THE REVERSE SPLIT HAS ALREADY TAKEN PLACE. NOT MUCH ROOM OR LOGIC FOR THE DOWN-SIDE BUT A TREMENDOUS AMOUNT OF LOGIC FOR HUGE GAINS SHORT/LONG TERM. BEST REGARDS
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News